Cove Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
925
+154
+20% +$157K 0.21% 83
2026
Q1
$709K Buy
771
+304
+65% +$308K 0.16% 103
2025
Q4
$502K Buy
467
+168
+56% +$161K 0.15% 110
2025
Q3
$228K Buy
299
+10
+3% +$7.44K 0.07% 149
2025
Q2
$225K Buy
+289
New +$225K 0.08% 145

Other funds holding LLY

Cove Private Wealth's LLY Position: Q2 2026 in Review

Cove Private Wealth increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $157K and bringing the position to 925 shares worth $1.11M. The position accounts for 0.21% of the portfolio, ranked #83.

Cove Private Wealth first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cove Private Wealth held 925 shares of Eli Lilly worth $1.11M as of Q2 2026.
  • Cove Private Wealth bought 154 Eli Lilly shares in Q2 2026, an estimated $157K.
  • Eli Lilly made up 0.21% of Cove Private Wealth's portfolio in Q2 2026, its #83 holding.
  • Cove Private Wealth first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cove Private Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.